These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 19755598)

  • 1. Adrenal imaging with multidetector CT: evidence-based protocol optimization and interpretative practice.
    Johnson PT; Horton KM; Fishman EK
    Radiographics; 2009; 29(5):1319-31. PubMed ID: 19755598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adrenal mass imaging with multidetector CT: pathologic conditions, pearls, and pitfalls.
    Johnson PT; Horton KM; Fishman EK
    Radiographics; 2009; 29(5):1333-51. PubMed ID: 19755599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adrenal masses: characterization with combined unenhanced and delayed enhanced CT.
    Caoili EM; Korobkin M; Francis IR; Cohan RH; Platt JF; Dunnick NR; Raghupathi KI
    Radiology; 2002 Mar; 222(3):629-33. PubMed ID: 11867777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinguishing benign from malignant adrenal masses: multi-detector row CT protocol with 10-minute delay.
    Blake MA; Kalra MK; Sweeney AT; Lucey BC; Maher MM; Sahani DV; Halpern EF; Mueller PR; Hahn PF; Boland GW
    Radiology; 2006 Feb; 238(2):578-85. PubMed ID: 16371582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of computed tomography histogram analysis and chemical-shift magnetic resonance imaging for adrenal mass characterization.
    Halefoglu AM; Yasar A; Bas N; Ozel A; Erturk SM; Basak M
    Acta Radiol; 2009 Nov; 50(9):1071-9. PubMed ID: 19863419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of CT histogram analysis and chemical shift MRI in the characterization of indeterminate adrenal nodules.
    Jhaveri KS; Wong F; Ghai S; Haider MA
    AJR Am J Roentgenol; 2006 Nov; 187(5):1303-8. PubMed ID: 17056920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adrenal masses: CT characterization with histogram analysis method.
    Bae KT; Fuangtharnthip P; Prasad SR; Joe BN; Heiken JP
    Radiology; 2003 Sep; 228(3):735-42. PubMed ID: 12954893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenal masses in patients with cancer: PET/CT characterization with combined CT histogram and standardized uptake value PET analysis.
    Perri M; Erba P; Volterrani D; Guidoccio F; Lazzeri E; Caramella D; Mariani G
    AJR Am J Roentgenol; 2011 Jul; 197(1):209-16. PubMed ID: 21701032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenal glands in hypovolemic shock: preservation of contrast enhancement at dynamic computed tomography.
    Ito K; Higashi H; Kanki A; Tamada T; Yamashita T; Yamamoto A; Watanabe S
    J Comput Assist Tomogr; 2010 Jul; 34(4):513-6. PubMed ID: 20657217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenal imaging for adenoma characterization: imaging features, diagnostic accuracies and differential diagnoses.
    Park JJ; Park BK; Kim CK
    Br J Radiol; 2016 Jun; 89(1062):20151018. PubMed ID: 26867466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenal adenomas and nonadenomas: assessment of washout at delayed contrast-enhanced CT.
    Szolar DH; Kammerhuber FH
    Radiology; 1998 May; 207(2):369-75. PubMed ID: 9577483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed enhanced CT of lipid-poor adrenal adenomas.
    Caoili EM; Korobkin M; Francis IR; Cohan RH; Dunnick NR
    AJR Am J Roentgenol; 2000 Nov; 175(5):1411-5. PubMed ID: 11044054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast-enhanced ultrasound in evaluation of adrenal lesions with CT/MRI correlation.
    Aggarwal A; Das CJ
    Br J Radiol; 2021 Apr; 94(1120):20201170. PubMed ID: 33439758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging of adrenal masses.
    Heinz-Peer G; Memarsadeghi M; Niederle B
    Curr Opin Urol; 2007 Jan; 17(1):32-8. PubMed ID: 17143109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed enhanced CT for differentiation of benign from malignant adrenal masses.
    Korobkin M; Brodeur FJ; Francis IR; Quint LE; Dunnick NR; Goodsitt M
    Radiology; 1996 Sep; 200(3):737-42. PubMed ID: 8756924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of indeterminate (lipid-poor) adrenal masses: use of washout characteristics at contrast-enhanced CT.
    Peña CS; Boland GW; Hahn PF; Lee MJ; Mueller PR
    Radiology; 2000 Dec; 217(3):798-802. PubMed ID: 11110946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The computed tomographic characteristics of adrenal tumors].
    Cheremisin VM; Pchelin IG; Savello VE; Fadeev VD; Krasnov LM
    Vestn Rentgenol Radiol; 1996; (2):22-5. PubMed ID: 8754117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adrenal masses: the value of additional fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) in differentiating between benign and malignant lesions.
    Okada M; Shimono T; Komeya Y; Ando R; Kagawa Y; Katsube T; Kuwabara M; Yagyu Y; Kumano S; Imaoka I; Tsuchiya N; Ashikaga R; Hosono M; Murakami T
    Ann Nucl Med; 2009 Jun; 23(4):349-54. PubMed ID: 19340526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation of adrenal adenomas from nonadenomas using CT histogram analysis method: a prospective study.
    Halefoglu AM; Bas N; Yasar A; Basak M
    Eur J Radiol; 2010 Mar; 73(3):643-51. PubMed ID: 19167179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenocortical carcinomas and adrenal pheochromocytomas: mass and enhancement loss evaluation at delayed contrast-enhanced CT.
    Szolar DH; Korobkin M; Reittner P; Berghold A; Bauernhofer T; Trummer H; Schoellnast H; Preidler KW; Samonigg H
    Radiology; 2005 Feb; 234(2):479-85. PubMed ID: 15671003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.